CoChat

Demethoxycurcumin Is A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life

Open access

The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.

Abstract

P-type ATPases catalyze the active transport of cations and phospholipids across biological membranes. Members of this large family are involved in a range of fundamental cellular processes. To date, a substantial number of P-type ATPase inhibitors have been characterized, some of which are used as drugs. In this work a library of natural compounds was screened and we first identified curcuminoids as plasma membrane H+-ATPases inhibitors in plant and fungal cells. We also found that some of the commercial curcumins contain several curcuminoids. Three of these were purified and, among the curcuminoids, demethoxycurcumin was the most potent inhibitor of all tested P-type ATPases from fungal (Pma1p; H+-ATPase), plant (AHA2; H+-ATPase) and animal (SERCA; Ca2+-ATPase) cells. All three curcuminoids acted as non-competitive antagonist to ATP and hence may bind to a highly conserved allosteric site of these pumps. Future research on biological effects of commercial preparations of curcumin should consider the heterogeneity of the material.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0163260

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Curcumin analogs employed in this study. Curcumin (Sigma-Aldrich) was initially identified as a hit in an in vitro screen for inhibitors of the plasma membrane H+-ATPase. Curcumin (CM, 1) demethoxycurcumin (DMCM, 2), bisdemethoxycurcumin (BDCM, 3) and 1,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-4,6-heptadien-3-one (6) were then purified as previous described [39, 62]. 6-shogaol (4) and dibenzylideneacetone (9) were obtained from Sigma-Aldrich. Tetrahydrocurcumin (5), 1,7-bis(3',4'-dimethoxyphenyl)-4,4-dimethyl-1,6-heptadien-3,5-dione (7) and 1-(3',4'-dimethoxyphenyl)-4,4-dimethyl-7-(4'-methoxyphenyl)-1,6-heptadien-3,5-dione (8) were synthesized as previously described in the literature[63].
Fig 1 Curcumin analogs employed in this study. Curcumin (Sigma-Aldrich) was initially identified as a hit in an in vitro screen for inhibitors of the plasma membrane H+-ATPase. Curcumin (CM, 1) demethoxycurcumin (DMCM, 2), bisdemethoxycurcumin (BDCM, 3) and 1,5-dihydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-4,6-heptadien-3-one (6) were then purified as previous described [39, 62]. 6-shogaol (4) and dibenzylideneacetone (9) were obtained from Sigma-Aldrich. Tetrahydrocurcumin (5), 1,7-bis(3',4'-dimethoxyphenyl)-4,4-dimethyl-1,6-heptadien-3,5-dione (7) and 1-(3',4'-dimethoxyphenyl)-4,4-dimethyl-7-(4'-methoxyphenyl)-1,6-heptadien-3,5-dione (8) were synthesized as previously described in the literature[63].CC BY · PubMed Central
Fig 2 Curcumin analogs inhibit plasma membrane H+-ATPases activity in a dose dependent manner. (A) ATPase activity measured on yeast plasma membranes from yeast strains expressing either A. thaliana PM H+-ATPase isoform AHA2 (left panel) or the endogenous yeast plasma membrane Pma1p (right panel) in the presence of 50 μM of the curcumin analogs, compounds 1–9, or vanadate, a P-type ATPase inhibitor. Values are mean ± S.E. (n = 3). Student’s t tests:*, p < 0.05; **, p < 0.01; ***, p < 0.001 relative to the control. (B) Dose-dependent inhibition of H+-ATPase activity of AHA2 (left) and Pma1p (right). Experiments were carried out in triplicates at different concentrations of CM (1), DMCM (2) and BDCM (3). Data were analyzed by using nonlinear regression tool and fitted to log(inhibitor) vs. normalized response (variable slope) for determination of IC50 values.
Fig 2 Curcumin analogs inhibit plasma membrane H+-ATPases activity in a dose dependent manner. (A) ATPase activity measured on yeast plasma membranes from yeast strains expressing either A. thaliana PM H+-ATPase isoform AHA2 (left panel) or the endogenous yeast plasma membrane Pma1p (right panel) in the presence of 50 μM of the curcumin analogs, compounds 1–9, or vanadate, a P-type ATPase inhibitor. Values are mean ± S.E. (n = 3). Student’s t tests:*, p < 0.05; **, p < 0.01; ***, p < 0.001 relative to the control. (B) Dose-dependent inhibition of H+-ATPase activity of AHA2 (left) and Pma1p (right). Experiments were carried out in triplicates at different concentrations of CM (1), DMCM (2) and BDCM (3). Data were analyzed by using nonlinear regression tool and fitted to log(inhibitor) vs. normalized response (variable slope) for determination of IC50 values.CC BY · PubMed Central
Fig 3 Curcumin analogs also inhibit proton pumping. (A-C) Proton mediated accumulation of ACMA in spinach plasma membrane vesicles after incubating with various concentrations of CM (1), DMCM (2) and BDCM (3). ATP stimulated H+-pumping is initiated upon addition of MgSO4. One representative of three independent experiments is shown for each compound (left panels). Proton transport activity was determined as initial rates of fluorescence quenching of ACMA probe (right panels). Values are mean ± S.E. (n = 3). Student’s t tests:*, p < 0.05; **, p < 0.01; ***, p < 0.001 relative to the control.
Fig 3 Curcumin analogs also inhibit proton pumping. (A-C) Proton mediated accumulation of ACMA in spinach plasma membrane vesicles after incubating with various concentrations of CM (1), DMCM (2) and BDCM (3). ATP stimulated H+-pumping is initiated upon addition of MgSO4. One representative of three independent experiments is shown for each compound (left panels). Proton transport activity was determined as initial rates of fluorescence quenching of ACMA probe (right panels). Values are mean ± S.E. (n = 3). Student’s t tests:*, p < 0.05; **, p < 0.01; ***, p < 0.001 relative to the control.CC BY · PubMed Central
Fig 4 Kinetic analysis of PM H+-ATPases inhibition by DMCM. ATP hydrolysis rate was plotted as function of [ATP] in the presence of the indicated amounts of DMCM; Yeast expressing A. thaliana PM H+-ATPase isoform AHA2 (A) and the endogenous yeast isoform Pma1p (B). Error bars represent standard errors of the mean for three independent trials.
Fig 4 Kinetic analysis of PM H+-ATPases inhibition by DMCM. ATP hydrolysis rate was plotted as function of [ATP] in the presence of the indicated amounts of DMCM; Yeast expressing A. thaliana PM H+-ATPase isoform AHA2 (A) and the endogenous yeast isoform Pma1p (B). Error bars represent standard errors of the mean for three independent trials.CC BY · PubMed Central
Fig 5 Dose-dependent inhibition of SERCA Ca2+-ATPase activity. Inhibition of ATP hydrolytic activity by addition of increasing amounts of compounds. Experiments were carried out in triplicate at different concentrations of CM (1), DMCM (2) and BDCM (3). Data were analyzed by using nonlinear regression tool and fitted to log(inhibitor) vs. normalized response (variable slope) for determination of IC50 values.
Fig 5 Dose-dependent inhibition of SERCA Ca2+-ATPase activity. Inhibition of ATP hydrolytic activity by addition of increasing amounts of compounds. Experiments were carried out in triplicate at different concentrations of CM (1), DMCM (2) and BDCM (3). Data were analyzed by using nonlinear regression tool and fitted to log(inhibitor) vs. normalized response (variable slope) for determination of IC50 values.CC BY · PubMed Central
Fig 6 Drop tests showing the sensitive response of S. cerevisiae mutant cells (encoding AHA2, aha2∆92 or Pma1p) to compounds 1–3. Serial dilutions of the yeast cultures are spotted on galactose (YPG) or glucose (YPD) media containing the indicated concentrations of CM (1), DMCM (2) or BDCM (3). Growth results were recorded after incubation for 3 days at 30°C. Results shown are representative data of three independent experiments for each compound.
Fig 6 Drop tests showing the sensitive response of S. cerevisiae mutant cells (encoding AHA2, aha2∆92 or Pma1p) to compounds 1–3. Serial dilutions of the yeast cultures are spotted on galactose (YPG) or glucose (YPD) media containing the indicated concentrations of CM (1), DMCM (2) or BDCM (3). Growth results were recorded after incubation for 3 days at 30°C. Results shown are representative data of three independent experiments for each compound.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 86 references

Research works printed but not linked: 1

  1. L Baunsgaard, 1998, The 14-3-3 proteins associate with the plant plasma membrane H+-ATPase to generate a fusicoccin binding complex and a fusicoccin responsive system, Plant Journal, 13, 661

Cited by

See all 26

Metadata

Authors
Dao, T. T., Sehgal, P., Tung, T. T., Møller, J. V., Nielsen, J., Palmgren, M., Christensen, S. B., & Fuglsang, A. T.
Affiliations
  • Aarhus University (DK)
  • University of Copenhagen (DK)
Corresponding author
Fuglsang, Anja Thoe
Venue
PLOS ONE
Published
2016-09-19
Volume
11
Issue
9
Pages
e0163260
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2521771935
Cited by
25
References
86
Citations by year
2026: 1 · 2025: 3 · 2024: 2 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 3 · 2019: 1 · 2018: 2 · 2017: 3
FWCI
0.98
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
  • University of Copenhagen's Excellency Program KU2016
  • Danmarks Grundforskningsfond (DK) (DNRF85)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › ATP Synthase and ATPases Research
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
demethoxycurcumin, curcuminoids, P-type ATPase, SERCA, AHA2, non-competitive inhibition, allosteric site, natural product screening, plasma membrane transport, fungal cells, plant cells
MeSH terms
Adenosine Triphosphatases, Curcumin, Enzyme Inhibitors, Saccharomyces cerevisiae, Spinacia oleracea, Diarylheptanoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Demethoxycurcumin Is A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life. https://app.cochat.ai/papers/10.1371/journal.pone.0163260
The paper
Dao, T. T., Sehgal, P., Tung, T. T., Møller, J. V., Nielsen, J., Palmgren, M., Christensen, S. B., & Fuglsang, A. T. (2016). Demethoxycurcumin Is A Potent Inhibitor of P-Type ATPases from Diverse Kingdoms of Life. PLOS ONE. https://doi.org/10.1371/journal.pone.0163260

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.